We are live on ! Find out more
OSH

Oak Street Health, Inc.

Delisted

OSH was delisted on the 1st of May, 2023.

245 hedge funds and large institutions have $8.82B invested in Oak Street Health, Inc. in 2021 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 78 increasing their positions, 59 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 48

32% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 59

8% more funds holding

Funds holding: 226245 (+19)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

22% less capital invested

Capital invested by funds: $11.2B → $8.82B (-$2.43B)

27% less call options, than puts

Call options by funds: $38.9M | Put options by funds: $53.6M

Holders
245
Holders Change
+19
Holders Change %
+8.41%
% of All Funds
4.29%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
69
Increased
78
Reduced
59
Closed
48
Calls
$38.9M
Puts
$53.6M
Net Calls
-$14.6M
Net Calls Change
-$38M
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$32.8M +$22.5M +418,430 +119%
Charles Schwab
27
Charles Schwab
California
$31M +$38M +708,032 +3,306%
Schroder Investment Management Group
28
Schroder Investment Management Group
United Kingdom
$30.4M +$9.2M +171,279 +31%
Norges Bank
29
Norges Bank
Norway
$29.9M -$2.76M -51,420 -7%
Deutsche Bank
30
Deutsche Bank
Germany
$29.4M -$6.19M -115,201 -14%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$26.7M +$4.51M +83,847 +15%
GGHC
32
Gilder Gagnon Howe & Co
New York
$23.5M -$40.2M -748,469 -58%
RSCM
33
Rock Springs Capital Management
Maryland
$18.8M +$3.55M +66,000 +18%
Holocene Advisors
34
Holocene Advisors
New York
$18.4M -$23.7M -440,715 -50%
Citadel Advisors
35
Citadel Advisors
Florida
$17.5M +$17.4M +323,276 +366%
Swiss National Bank
36
Swiss National Bank
Switzerland
$16.2M -$575K -10,700 -3%
CWG
37
C WorldWide Group
Denmark
$15.9M +$7.9M +147,000 +64%
RCW
38
Rheos Capital Works
Japan
$15.5M
1832 Asset Management
39
1832 Asset Management
Ontario, Canada
$15M +$15M +279,080 +507%
DIG
40
Dragoneer Investment Group
California
$14.9M
Bank of New York Mellon
41
Bank of New York Mellon
New York
$13M +$4.54M +84,573 +38%
CA
42
CapWealth Advisors
Tennessee
$12.8M
Federated Hermes
43
Federated Hermes
Pennsylvania
$12.8M
PCM
44
Peregrine Capital Management
Minnesota
$11.8M -$163K -3,040 -1%
NIP
45
Nicholas Investment Partners
California
$11.8M -$5.74M -106,794 -28%
UBS Group
46
UBS Group
Switzerland
$11.7M +$4.36M +81,179 +42%
DT
47
Diversified Trust
Tennessee
$11.5M
MC
48
Maverick Capital
Texas
$11.5M
Legal & General Group
49
Legal & General Group
United Kingdom
$11.4M +$1.06M +19,704 +8%
Bank of America
50
Bank of America
North Carolina
$11.3M +$9.53M +177,282 +199%

OSH Hedge Fund Activity: Q3 2021 in Review

245 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Oak Street Health, Inc. (OSH) for Q3 2021, worth a combined $8.82B — down 22% from $11.2B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new OSH positions and 48 closed out — a net gain of 21 holders — while 78 added to existing stakes and 59 trimmed.

The largest buyer was Capital International Investors, adding an estimated $266M. The largest seller was Marshall Wace North America, exiting entirely with an estimated $53.5M sold.

  • 245 institutional investors held Oak Street Health, Inc. (OSH) as of Q3 2021, up from 226 in Q2 2021.
  • Funds reported $8.82B of Oak Street Health, Inc. stock for Q3 2021, down 22% quarter-over-quarter.
  • 69 funds opened new Oak Street Health, Inc. positions in Q3 2021 and 48 closed out, a net change of +21 holders.
  • The largest Oak Street Health, Inc. buyer in Q3 2021 was Capital International Investors, an estimated $266M added.
  • The largest Oak Street Health, Inc. seller in Q3 2021 was Marshall Wace North America, an estimated $53.5M sold.

Based on aggregated 13F filings for Q3 2021.